Here are suggestions for improving CR efficiency, speed, and process

August 2009
Clinical Trials Administrator;Aug2009, Vol. 7 Issue 8, p88
The article presents suggestions from experts on improving clinical trial (CT) efficiency. These include holding simultaneous study review meetings, building public trust by demonstrating efficiency, and following proven best practices. It is also suggested to systemize the contracting process, which according to David M. Dilts, director of clinical research for the Knight Cancer Institute, is highly individualized, that is inefficient and unnecessary.


Related Articles

  • The outsiders: Unique team hopes to re-engineer the clinical trial process.  // Clinical Trials Administrator;Aug2009, Vol. 7 Issue 8, p85 

    The article deals with the collaboration of David M. Dilts, a professor of management, with Steven K. Cheng and Joshua Crites to redesign the way medical research is conducted to improve the efficiency of conducting clinical trials and save cost of delays in marketing the treatments. Dilts says...

  • CRO Selection &0026; Management. Glass, Harold E.; Beaudry, Daniel P. // Applied Clinical Trials;Apr2009, Vol. 18 Issue 4, p48 

    The article discusses the importance of outsourcing in managing clinical research organizations (CROs). It says that outsourcing is a factor in improving the speed ad cost effectiveness of clinical studies. Meanwhile, managing outsourcing involves annual budgeting, the use of bid-grids, CRO...

  • Implementation and Usage of Data Monitoring Committees. Bussom, Donelle; Winter, Louise A. // Applied Clinical Trials;Oct/Nov2014, Vol. 23 Issue 10/11, p24 

    The article focuses on data monitoring committees (DMCs) which are created to advise a clinical research organization during the conduct of clinical trials. It reports that DMCs work to preserve the integrity of the trial and protect the safety of study participants. Further discussed are models...

  • A New Year and New Challenges. Hindin, Toby Jane // Applied Clinical Trials;Jan2004, Vol. 13 Issue 1, p12 

    Highlights the Applied Clinical Trials 2003 summit focusing on the clinical trials held in London, England. Problems in clinical trials; Growth on the practice of outsourcing in clinical trials; Interaction within medical and marketing departments.

  • Transition from congress abstract to full publication for clinical trials presented at laser meetings. Akbari-Kamrani, Marjan; Shakiba, Behnam; Parsian, Sana // Lasers in Medical Science;Sep2008, Vol. 23 Issue 3, p295 

    The present study aims to identify (1) what proportion of abstracts of clinical trials presented at The American Society for Laser Medicine and Surgery (ASLMS) annual meetings are published as full reports, (2) time to publication, and (3) factors that may predict the publication of research in...

  • Best practices sharing: Setting up a professional clinical research unit in India. Divate, Uma; Das, Soma; Bhosale, Neelambari; Divate, Pathik // Perspectives in Clinical Research;Jan-Mar2014, Vol. 5 Issue 1, p37 

    The Drug Controller General of India has recently come up with very stringent laws to tighten the regulatory framework around clinical trials. One-way of improving the credibility of India and its researchers in the eyes of the regulators, sponsors and the general public is through professional...

  • 20 Years Partnering in Clinical Trials. Henderson, Lisa // Applied Clinical Trials;Apr2011, Vol. 20 Issue 4, p10 

    The article offers the author's insights on the Partnerships in Clinical Trials conference held in Phoenix, Arizona in March 2011. She notes that outsourcing in the pharmaceutical industry leads to business partnerships. She also mentions the Staff Quality and Models report which surveyed the...

  • Unique Challenges in Asia-Pac.  // Applied Clinical Trials;Apr2011, Vol. 20 Issue 4, Special section p2 

    The article reports on the survey conducted by the PRTM Management Consultants Inc. on the motivation for organizing clinical trials in Asia in 2011. It notes that the survey presented analysis of Asian trials by country from 2003 to 2008. It mentions the results of the study that the...

  • The value of CROs in drug development. Copestake, Andrew // Pharmaceutical Technology Europe;Nov2006, Vol. 18 Issue 11, p59 

    This article discusses why outsourcing is becoming more popular the various outsourcing models available, and the impact of outsourcing on the European clinical trials market.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics